Post-COVID Cognitive Symptoms & Brain Fog

Conditions We Treat

Post-COVID Cognitive Symptoms

Brain fog, fatigue, and cognitive difficulties following COVID-19 infection are among the most prevalent and least well-served post-acute presentations of the pandemic. They have measurable neurobiological underpinnings — and they are beginning to respond to targeted clinical intervention.

Off-Label

rTMS for post-COVID cognitive symptoms is an off-label application in Australia, offered under psychiatrist oversight with full informed consent. Where symptoms coexist with treatment-resistant depression, Medicare rebates under MBS 14216 and MBS 14217 may apply. All care is AHPRA-compliant.

Understanding the condition

What are post-COVID cognitive symptoms?

Post-COVID condition — commonly referred to as Long COVID — affects an estimated 10–20% of people who experience a COVID-19 infection, regardless of initial severity. Among its most functionally disabling features are cognitive symptoms: brain fog, difficulty concentrating, impaired memory, mental fatigue, and word-finding difficulties that persist weeks to months after acute infection has resolved.

These symptoms have measurable neurobiological correlates. Neuroimaging studies demonstrate persistent changes in brain structure and function following COVID-19 — including reduced grey matter in frontal and temporal regions, altered connectivity in prefrontal networks, and markers of neuroinflammation. These are not psychosomatic or subjective experiences; they reflect genuine changes in neural architecture.

Contributing mechanisms include neuroinflammation driven by immune dysregulation, autonomic nervous system disruption, mitochondrial dysfunction, microclotting in cerebral vasculature, and reactivation of latent viral reservoirs including Epstein-Barr virus. The multi-mechanism nature of Long COVID means that management — like the condition itself — is complex and individualised.

Post-COVID cognitive symptoms frequently coexist with fatigue, mood disturbance, anxiety, and sleep disruption — a constellation that significantly impairs work, relationships, and daily functioning, and that warrants clinical attention as a serious, multidimensional condition.

Symptoms commonly reported

Brain fog — mental cloudiness, difficulty thinking clearly or quickly

Impaired concentration and attention — unable to sustain mental effort

Memory difficulties — particularly working memory and recall

Word-finding difficulties and cognitive slowing

Cognitive fatigue — mental exhaustion disproportionate to activity

Post-exertional malaise — worsening of symptoms following mental or physical effort

The neuroscience

Why post-COVID brain fog is a neurological condition

Neuroinflammation

Persistent immune activation following COVID-19 drives neuroinflammatory processes that impair synaptic function and disrupt the prefrontal networks underpinning attention, working memory, and cognitive control.

Autonomic dysregulation

Disruption of the autonomic nervous system — including postural orthostatic tachycardia syndrome (POTS) — impairs cerebral blood flow and oxygenation, compounding cognitive difficulty and fatigue independently of direct neural damage.

Prefrontal circuit disruption

Neuroimaging demonstrates reduced connectivity and grey matter changes in prefrontal regions — the same circuits targeted by rTMS — explaining why prefrontal neuromodulation is a rational therapeutic approach for this population.

Our approach

How Brain Aid Clinics supports post-COVID presentations

Post-COVID cognitive symptoms are heterogeneous — the mechanisms driving one person’s presentation may differ significantly from another’s. Thorough clinical assessment before any intervention is non-negotiable.

01 Clinical assessment — characterising the presentation

Post-COVID cognitive symptoms overlap with depression, anxiety, sleep disorder, and post-exertional malaise — each of which has different management implications. A thorough assessment characterises which mechanisms are dominant and what interventions are most likely to be effective for your specific presentation.

02 rTMS — prefrontal neuromodulation

Prefrontal rTMS targets the cortical circuits that neuroimaging studies demonstrate are disrupted in Long COVID. Emerging evidence, including controlled trials, shows improvements in cognitive function, fatigue, and mood in post-COVID populations. MRI-guided neuronavigation ensures stimulation accuracy to your individual brain anatomy. Offered off-label under psychiatrist oversight.

03 The TMF Programme

Thought, Movement, and Food — carefully calibrated for post-COVID presentations where post-exertional malaise requires a graded, paced approach to physical activity. Dietary guidance targets neuroinflammation and mitochondrial support. Cognitive strategies address the psychological impact and the pacing approach that Long COVID management requires.

04 Coordination with your treating team

Post-COVID is a multisystem condition. We work alongside GPs, immunologists, cardiologists (for autonomic dysfunction), neurologists, and allied health professionals to ensure our contribution is coherent with your broader management plan. Reports to your referring team are provided at agreed intervals.

Common Questions

What patients ask us

How long do post-COVID cognitive symptoms last? +

Duration varies significantly between individuals. Some people experience improvement within weeks to months; others have symptoms that persist for a year or more. The mechanisms driving Long COVID are heterogeneous — which means recovery trajectories differ, and there is no reliable universal timeline. What we do know is that targeted intervention — addressing the neurobiological mechanisms rather than simply waiting — can support recovery. Early clinical assessment and management are preferable to watchful waiting alone.

Is post-COVID brain fog the same as depression or anxiety?

They are distinct, though they frequently coexist. Post-COVID cognitive symptoms reflect neurobiological changes — neuroinflammation, prefrontal disruption, autonomic dysregulation — that are not the same as primary anxiety or depression, even where mood symptoms are present. Distinguishing between them matters for treatment: a presentation driven primarily by neuroinflammation may respond differently to one driven primarily by mood dysregulation. A thorough clinical assessment identifies the dominant mechanisms and guides the appropriate intervention pathway.

Does rTMS help with Long COVID brain fog?

Emerging evidence is promising. Several controlled trials and case series report improvements in cognitive function, fatigue, and mood following prefrontal rTMS in post-COVID populations — consistent with the neuroimaging evidence showing disruption in the circuits that rTMS targets. The evidence base is growing but remains early relative to more established indications. rTMS for post-COVID cognitive symptoms is off-label in Australia and offered under psychiatrist oversight with full informed consent, with realistic expectations established before treatment begins.

Is rTMS covered by Medicare for Long COVID? +

Medicare rebates for rTMS (MBS 14216, 14217) are limited to treatment-resistant depression. They do not cover rTMS for post-COVID cognitive symptoms as a standalone indication. However, where Long COVID coexists with treatment-resistant depression — which is common — Medicare rebates may apply to the depression component of treatment. Our team will clarify what applies to your specific presentation at assessment.

What should I expect at my first appointment?

Your first appointment is a clinical assessment. Your treating clinician will review your COVID infection history, the timeline and nature of your cognitive symptoms, your current functional impact, any other Long COVID features (fatigue, autonomic symptoms, mood), and previous treatments. The goal is to characterise your specific presentation before recommending any intervention. You leave with a clinical picture and a realistic plan — not a course of treatment sold in advance of understanding your situation.

Clinical and regulatory note: rTMS for post-COVID cognitive symptoms is an off-label application in Australia, offered under psychiatrist oversight with full informed consent. Medicare rebates (MBS 14216, MBS 14217) apply for treatment-resistant depression only. The evidence base for rTMS in post-COVID presentations is emerging and evolving. All information is for general informational purposes and does not constitute medical advice. Please consult a qualified health professional. Brain Aid Clinics operates within AHPRA-compliant clinical and regulatory boundaries. ABN 76 664 676 420.

Conditions We Treat